Hunter syndrome
Alternate Names : Mucopolysaccharidosis type II, Iduronate sulfatase deficiency
Treatment
The U.S. Food and Drug Administration has approved the first treatment for Hunter syndrome. The medicine, called idursulfase (Elaprase), is given through a vein (intravenously). Talk to your doctor for more information. Bone marrow transplant has been tried for the early-onset form, but the results can vary.
Each health problem should be treated separately.
Prognosis (Expectations)
People with the early-onset (severe) form usually live for 10 - 20 years. People with the late-onset (mild) form usually live 20 - 60 years.
Complications
- Airway obstruction
- Carpal tunnel syndrome
- Hearing loss that gets worse over time
- Loss of ability to complete daily living activities
- Joint stiffness that leads to contractures
- Mental function that gets worse over time
Calling Your Health Care Provider
Call your health care provider if: - You or your child has a group of these symptoms
- You know you are a genetic carrier and are considering having children
|
Previous
